Dercum’s Disease Market Projected At high CAGR | Major Key Player- Pfizer, Inc., Abbvie, Inc., Johnson & Johnson, GlaxoSmithKline Plc, Merck & Co., Inc., Novartis, Hoffman, La Roche AG, Eli Lily and Company, AstraZeneca PLC, Amgen and others. by 2023
The global dercum’s disease market is expected to witness significant growth over the forecast period. Dercum’s disease also known as adipose Dolorosa is a rare condition characterized by multiple painful growths of fatty tissue called lipomas. The disease mainly affects the torso, the upper arms, and upper legs. Dercum’s disease majorly occurs in adults and more women are affected than men. According to a review in the Orphanet Journal of Rare Diseases, dercum’s disease is about 5 to 30 times more common in women. Additionally, dercum’s disease is hard to diagnose and majorly biopsy of the lipomas is carried out for confirmation of the condition.
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/6350
The global dercum’s disease market is expected to be driving owing to the growing healthcare expenditures in the developed as well as developing economies, rising prevalence of rare diseases, growing occurrences of lipomas, and rising research and development activities. However, lack of awareness about the disease is likely to hamper the growth of the market over the forecast period.
The global dercum’s disease market has been segmented into treatment, distribution channel, and end-user.
The market, on the basis of treatment, has been segmented into surgery, medication, liposuction, electrotherapy, acupuncture, and others. The medication segment has been further segmented into diuretics, non-steroidal anti-inflammatory drugs, corticosteroids, and others.
The market, by distribution channel, has been segmented into retail pharmacies, hospital pharmacies, and others.
The market, by end-user, has been segmented into hospital & clinics, ambulatory surgical centers, and others.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The dercum’s disease market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European dercum’s disease market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The dercum’s disease market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The dercum’s disease market in the Middle East & Africa has been segmented into the Middle East and Africa.
Pfizer, Inc., Abbvie, Inc., Johnson & Johnson, GlaxoSmithKline Plc, Merck & Co., Inc., Novartis, Hoffman, La Roche AG, Eli Lily and Company, AstraZeneca PLC, Amgen, Valeant Pharmaceuticals, Syneron Medical, St. Jude Medical Inc. and Alimed, Inc. are some players in the global dercum’s disease market.
Regional Market Summary
Geographically, the Americas is anticipated to dominate the global dercum’s disease market owing to a well-established healthcare sector, rising prevalence of rare diseases, and growing healthcare expenditure. According to the data published in the National Center for Biotechnology Information (NCBI) in 2017, about 25 to 30 million American population live with a rare disease. Additionally, favorable reimbursement scenario and a relatively large number of research and development (R&D) activities contribute to the growth of the market. According to the Centers for Disease Control and Prevention (CDC), in the US, the total national health expenditure was USD 3.2 trillion in the year 2015.
Europe is expected to hold the second largest position in the global dercum’s disease market. The market growth in this region is attributed to the availability of funds for research and increasing healthcare expenditure. According to the Office for National Statistics, gross domestic expenditure on research and development (R&D) was Euro 33.1 billion (USD 35.2 billion) in 2016.
The dercum’s disease market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. Asia-Pacific is anticipated to be the fastest growing region in the market due to the growing disposable income, continuously developing economies, and increasing government funding for the healthcare sector. Additionally, regional expansions by market players in the region are considered to be contributing to the market growth.
The Middle East & Africa has the least market share in the global market. Majority of the market of this region is expected to be held by the Middle East region due to a well-developed healthcare sector and growing government initiatives for the healthcare sector.
Apply for Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/6350
Detailed Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.2 Scope Of The Study
2.2.1 Research Objective
Chapter 3. Research Methodology
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
Send An Enquiry @ https://www.marketresearchfuture.com/enquiry/6350
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Phone: +1 646 845 9312
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Dercum’s Disease Market Projected At high CAGR | Major Key Player- Pfizer, Inc., Abbvie, Inc., Johnson & Johnson, GlaxoSmithKline Plc, Merck & Co., Inc., Novartis, Hoffman, La Roche AG, Eli Lily and Company, AstraZeneca PLC, Amgen and others. by 2023 here
News-ID: 1297211 • Views: 456
More Releases from Market Research Future
Clinical Trial Management System Market Demand, Industry Share, Size, Applicatio …
Clinical Trial Management System Market Analysis by Type (Enterprise Clinical Trial Management System), Delivery Model (Licensed Enterprise), Component (Service) and End-User (Medical Device Manufacturers), and Regional Competitive Share, Size and Trends, 2018-2023 Market Overview Clinical Trial Management System Market is mostly a software system which helps to plan, prepare, and manage a large amount of clinical trials data that is produced by biotechnological and pharmaceutical companies. Drug research has gained momentum in
Reusable Satellite Launch Vehicle (RSLV) Market 2019-2023 | Report Information b …
Global Reusable Satellite Launch Vehicle Market Report Information by Configuration (Single Stage, Multiple Stage), by Type (Partially Reusable, Fully Reusable), Vehicle Weight (Up to 4,000lbs, 4000-9000lbs, Over 9000lbs), & by Region - Forecast Till 2023 The Reusable satellite launch vehicle market is estimated to witness a CAGR of more than 12% during the forecast period from 2018 to 2023. The key players in the reusable satellite launch vehicle market are Airbus S.A.S
Bakery Enzymes Market Global Research Report and Top Key Players: AB Enzymes Gmb …
Market Overview The increasing demand for bakery products in the food and beverage industry including, bread, cookies, and pastries are raising the demand for bakery enzymes at a global level. Enzymes are an important ingredient used in most bakery products. There are two scenarios regarding the use of enzymes, either the enzymes are used to convert the raw material into the main product, or the enzymes are used as additives to
Commercial Airport Lighting Market 2019-2023 | Worldwide Overview By Technology, …
Global Commercial Airport Lighting Market Research Report: Information by Technology (LED, Non-LED), by Application (Airside Lighting, Terminal Lighting, Landside Lighting), and by Region — Forecast till 2023 Honeywell International Inc., (US), ADB SAFEGATE (US), ABB (Switzerland), vosla GmBH (Germany), Avlite (Australia), Carmanah (Canada), Eaton (Ireland), atg airports limited (UK), Avionics Group (US), and HELLA GmBH & Co. KGaA (Germany) are some of the prominent players profiled in MRFR Analysis and are
More Releases for Euro
Euro Ophthalmology 2019
The 2nd European Congress on Ophthalmology going to be held amid March 21-22, 2018 at Amsterdam, The Netherlands, which unites a one of a kind and worldwide blend of substantial and medium pharmaceutical, biotech and symptomatic or diagnostic organizations, leading universities and clinical research companies making the meeting an ideal stage to share understanding, encourage coordinated efforts crosswise over industry and the scholarly community, and assess rising advancements over the
Euro Surgical Pathology 2018
Rome, Italy welcomes you all to share Medical Knowledge and Experience at our upcoming "14th International Conference on Surgical Pathology and Cancer Diagnosis, May 17-18, 2018. Some of the main sessions "to-be-covered" are • Surgical Pathology and Diagnosis • Cancer Pathology • Breast Pathology • Gynecologic Pathology • Gastrointestinal and Liver Pathology • Neuro Surgery and Pathology • Oral and Maxillofacial Pathology • Dermatopathology • Genitourinary Pathology • Cytopathology & many more! Holiday Inn Rome - Aurelia Via Aurelia Km 8,400 00163 Roma Italy
20th Euro Congress on Psychiatrists and Psychologists
Theme: Achieving mental wellness by understanding human mind through Psychiatric approaches Description: Euro Psychiatrists 2017 (CME Accredited Event) will provide an opportunity for all stakeholders working on mental health issues to talk about their work. Euro Psychiatrists 2017 will congregate renowned speakers, principal investigators, experts, psychiatrist and researchers from both academia and health care industry will join together to discuss their views and research. Conference highlights 1. Psychiatry 2. Psychology 3. Child and Adolescent Psychology 4. Psychosis And Adverse
17th Euro Biotechnology Congress
Conference Series LLC extends its warm welcome to 17th Euro Biotechnology Congress during September 25-27, 2017 at Berlin, Germany with a theme “Novel Trends and Innovations in Biotechnology for Making Life Better”. Conference Series LLC through its Open Access Initiative is committed to make genuine and reliable contributions to the scientific community. Scope and Importance Euro Biotechnology Conference aims to bring together the Professors, Researchers, scientists, business giants, and technocrats to provide
Euro Façade Tech Glazing Systems
Virtually any type of glazing system can be used with structural glass facades. Check out the options with Euro Façade Tech. FRAMED Framed systems support the glass continuously along two or four sides. There are many variations of framed systems, most of which fall into two general categories. Conventional unitized curtainwall systems are seldom used with structural glass facades. STICK Stick-built glass facades are a method of curtainwall construction where much of the fabrication
Traveltext's alternative Euro 2016
You don’t even have to be a sports fan to know that this summer, the England football team will be heading off to the latest major international tournament with the hopes of a nation resting on the shoulders of the likes of Wayne Rooney, Jamie Vardy and Dele Alli. The fact that the tournament has expanded this year to include no fewer than 24 nations means that the eyes of Europe